Table 1.
Cross-Sectional Cohort (n = 34) Characteristics
| Characteristic | All Participants (n = 34) | |
|---|---|---|
| Gender | 27 males (79%), 7 females (21%) | |
| Race | 16 Black (47%), 18 White (53%) | |
| Ethnicity | 0% Hispanic or Latino | |
| Onset ARTa | 8 acute, 26 chronic | |
| Median | Range | |
| Age, years (range) | 49 | 20–66 |
| CD4 nadir (cells/μL) | 287 | 9–789 |
| Years of ART suppressionb | 5.0 | 0.6–13.2 |
| IUPMc | 0.68 | 0.02–8.3 |
a
Acute: combination antiretroviral therapy (cART) begun within 30 days of negative or discordant HIV antigen test.
b
Durable suppression defined as time from ≤40 copies/mL to date of T cell measurement. Numbers based on 33 participants because status of one participant unknown.
c
IUPM (infectious units per million) numbers based on study data of 19 participants.